Business Description
MindBio Therapeutics Corp
NAICS : 541714
SIC : 3741
ISIN : CA60256C1086
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | -17.87 | |||||
Debt-to-Equity | -0.91 | |||||
Debt-to-EBITDA | -1.67 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -92.07 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.92 | |||||
9-Day RSI | 40.3 | |||||
14-Day RSI | 42.77 | |||||
6-1 Month Momentum % | -33.33 | |||||
12-1 Month Momentum % | -25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.2 | |||||
Quick Ratio | 0.2 | |||||
Cash Ratio | 0.16 | |||||
Days Sales Outstanding | 15.29 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -7.96 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -419.07 | |||||
Net Margin % | -563.82 | |||||
FCF Margin % | -152.94 | |||||
ROA % | -780.22 | |||||
ROIC % | -187.48 | |||||
ROC (Joel Greenblatt) % | -547.73 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.25 | |||||
EV-to-EBIT | -2.81 | |||||
EV-to-EBITDA | -2.89 | |||||
EV-to-Revenue | 13.88 | |||||
EV-to-FCF | -9.86 | |||||
Earnings Yield (Greenblatt) % | -35.62 | |||||
FCF Yield % | -25.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MindBio Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.561 | ||
EPS (TTM) (C$) | -0.023 | ||
Beta | 0 | ||
Volatility % | 170.37 | ||
14-Day RSI | 42.77 | ||
14-Day ATR (C$) | 0.002373 | ||
20-Day SMA (C$) | 0.0275 | ||
12-1 Month Momentum % | -25 | ||
52-Week Range (C$) | 0.015 - 0.085 | ||
Shares Outstanding (Mil) | 133.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MindBio Therapeutics Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MindBio Therapeutics Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
MindBio Therapeutics Corp Frequently Asked Questions
What is MindBio Therapeutics Corp(XCNQ:MBIO)'s stock price today?
When is next earnings date of MindBio Therapeutics Corp(XCNQ:MBIO)?
Does MindBio Therapeutics Corp(XCNQ:MBIO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |